- Eiger to Present at Jefferies 2019 London Healthcare Conference
- Eiger Announces Peginterferon Lambda - Lonafarnib Combination Interim Results in Hepatitis Delta Virus (HDV) Infection from Phase 2 LIFT Study During Late-Breaker Oral Presentation at AASLD 2019
- Eiger BioPharmaceuticals Reports Third Quarter 2019 Financial Results and Provides Business Update
- Eiger Announces Peginterferon Lambda Combination Therapy for Treatment of Chronic Hepatitis Delta Virus (HDV) Infection to be Featured in a Late-Breaking Oral Presentation at AASLD 2019
- Eiger to Present at Cantor 2019 Global Healthcare Conference
- Eiger BioPharmaceuticals to Participate in September Conferences
Eiger BioPharmaceuticals Inc (EIGR:NMQ) closed at 11.65, 38.69% above the 52 week low of 8.40 set on Nov 20, 2018.
8.40Nov 20 201815.33Apr 03 2019
Markit short selling activity
|Market cap||275.32m USD|
|EPS (TTM)||-3.33 |
Data delayed at least 15 minutes, as of Nov 19 2019 21:00 GMT.